SWI/SNF Complex Assembly Pathways for Stable Native Architecture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The lack of high-resolution structures and understanding of mammalian SWI/SNF complex architecture hinders the comprehension of their function and the impact of disease-associated mutations, due to instability of subunits, non-representative in vitro assemblies, and the need for large quantities of purified complexes with minimal heterogeneity.
Innovation Solution
Elucidation of the architecture and assembly pathway of mammalian SWI/SNF complexes through complex and subcomplex purification, mass-spectrometry, cross-linking mass-spectrometry, systematic genetic manipulation, and evolutionary analyses, revealing the requirements for complex formation and stability, and the impact of mutations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If subunits are expressed individually for structural studies, then complex assembly can be analyzed, but subunit instability prevents reliable complex formation
Solution Approach 1:
The patent applies preliminary action by identifying and expressing subunits in a specific sequential order that mimics their natural assembly pathway. Core subunits are expressed and stabilized first, creating a foundation for subsequent subunit addition. This pre-established framework prevents instability issues that would arise from random or simultaneous expression of all subunits.
Solution Approach 2:
The patent segments the SWI/SNF complex into modular subcomplexes that can be assembled stepwise. Rather than attempting to express all subunits simultaneously, the research divides the complex into functional modules (e.g., ATPase module, regulatory module, DNA-binding module) that can be stabilized and characterized independently before being integrated into the full complex.
2Ease of operation
If in vitro assemblies are used to study complex structure, then complex formation can be observed, but the assemblies are non-representative of native complexes
Solution Approach 1:
The patent employs feedback mechanisms by using cross-linking mass spectrometry data and native complex comparisons to guide and refine in vitro assembly conditions. Experimental results from native complex analysis feed back into optimizing expression conditions, subunit ratios, and buffer compositions for in vitro reconstituted complexes, ensuring they progressively resemble native structures more accurately.
Solution Approach 2:
The patent systematically varies critical parameters such as subunit expression ratios, incubation temperatures, salt concentrations, and pH levels to optimize in vitro complex assembly. By adjusting these parameters based on native complex characteristics, the research produces in vitro assemblies that more closely mimic the structure and composition of native SWI/SNF complexes.
3Quantity of substance
If large quantities of purified complexes are obtained for structural analysis, then high-resolution structures can be determined, but complex heterogeneity increases
Solution Approach 1:
The patent applies preliminary purification and characterization steps to define the composition and structure of SWI/SNF complexes before scaling up production. By establishing the precise subunit composition and structural features of native complexes in initial experiments, the research creates a reference framework that guides large-scale purification protocols, ensuring that abundant complex preparations maintain structural fidelity and homogeneity.
Data Source
AI summary
The present invention is based, in part, on the novel discovery of the architecture and assembly pathway of three different classes of mammalian SWI/SNF complexes, compositions comprising the isolated modified SWI/SNF complexes, and methods of screening for modulators of the function and/or stability of same.